Department of Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research (DZIF), Partner Site Hamburg - Lübeck - Borstel - Riems, Hamburg, Germany.
Sci Rep. 2023 Feb 10;13(1):2443. doi: 10.1038/s41598-023-29410-5.
Respiratory infections are one of the most common causes of death among children under the age of five years. Data on prevalence and relevance of specific organisms in African children are still lacking. This case-control-study investigated prevalence and relevance of specific organisms in Ghanaian children admitted to hospital with symptoms of lower respiratory tract infection (LRTI). Pharyngeal swabs were taken and tested by PCR for 19 respiratory isolates. Adjusted odds ratios (aORs) were calculated to estimate associations between isolates and admission with LRTI. Population attributable fractions (PAFs) were calculated to assess the proportion of LRTI cases due to a particular pathogen. The study included 327 cases and 562 controls. We found associations between detection and admission for LRTI for influenza (aOR 98.6; 95% confidence interval (CI) 20.0-1789.6), respiratory syncytial virus (aOR 40.2; 95% CI 7.2-758.6), H. influenzae (aOR 4.1; 95% CI 2.2-7.9) and S. pneumoniae (aOR 2.4; 95% CI 1.7-3.4). PAFs ≥ 10% were observed for S. pneumoniae (30%; 95% CI 26-42), H. influenzae (10%; 95% CI 2-19) and influenza (10%; 95% CI 2-18). This study highlights the need for heightened surveillance and development of effective vaccines for respiratory pathogens other than SARS-CoV-2 in the future.
呼吸道感染是 5 岁以下儿童死亡的最常见原因之一。关于非洲儿童特定病原体的流行率和相关性的数据仍然缺乏。本病例对照研究调查了加纳因下呼吸道感染(LRTI)症状住院的儿童中特定病原体的流行率和相关性。采集咽拭子并通过 PCR 检测 19 种呼吸道分离物。计算调整后的优势比(aOR)来估计分离物与 LRTI 入院之间的关联。计算人群归因分数(PAF)来评估特定病原体导致的 LRTI 病例的比例。该研究包括 327 例病例和 562 例对照。我们发现流感(aOR 98.6;95%置信区间(CI)20.0-1789.6)、呼吸道合胞病毒(aOR 40.2;95%CI 7.2-758.6)、流感嗜血杆菌(aOR 4.1;95%CI 2.2-7.9)和肺炎链球菌(aOR 2.4;95%CI 1.7-3.4)的检出与 LRTI 入院之间存在关联。肺炎链球菌(30%;95%CI 26-42)、流感嗜血杆菌(10%;95%CI 2-19)和流感(10%;95%CI 2-18)的 PAFs≥10%。本研究强调了未来需要加强对 SARS-CoV-2 以外的呼吸道病原体的监测和开发有效的疫苗。